335 related articles for article (PubMed ID: 10699931)
1. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells.
Parr C; Hiscox S; Nakamura T; Matsumoto K; Jiang WG
Int J Cancer; 2000 Feb; 85(4):563-70. PubMed ID: 10699931
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4.
Hiscox S; Parr C; Nakamura T; Matsumoto K; Mansel RE; Jiang WG
Breast Cancer Res Treat; 2000 Feb; 59(3):245-54. PubMed ID: 10832594
[TBL] [Abstract][Full Text] [Related]
3. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
Davies G; Mason MD; Martin TA; Parr C; Watkins G; Lane J; Matsumoto K; Nakamura T; Jiang WG
Int J Cancer; 2003 Sep; 106(3):348-54. PubMed ID: 12845672
[TBL] [Abstract][Full Text] [Related]
4. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant.
Parr C; Davies G; Nakamura T; Matsumoto K; Mason MD; Jiang WG
Biochem Biophys Res Commun; 2001 Aug; 285(5):1330-7. PubMed ID: 11478803
[TBL] [Abstract][Full Text] [Related]
5. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
6. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
Martin TA; Parr C; Davies G; Watkins G; Lane J; Matsumoto K; Nakamura T; Mansel RE; Jiang WG
Carcinogenesis; 2003 Aug; 24(8):1317-23. PubMed ID: 12807719
[TBL] [Abstract][Full Text] [Related]
7. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
Lai RX; Yuan SZ; Nakamura T
Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
Jiang WG; Hiscox SE; Parr C; Martin TA; Matsumoto K; Nakamura T; Mansel RE
Clin Cancer Res; 1999 Nov; 5(11):3695-703. PubMed ID: 10589789
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
Date K; Matsumoto K; Kuba K; Shimura H; Tanaka M; Nakamura T
Oncogene; 1998 Dec; 17(23):3045-54. PubMed ID: 9881707
[TBL] [Abstract][Full Text] [Related]
11. Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses.
Matsumoto K; Kataoka H; Date K; Nakamura T
J Biol Chem; 1998 Sep; 273(36):22913-20. PubMed ID: 9722511
[TBL] [Abstract][Full Text] [Related]
12. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
EXS; 1993; 65():311-28. PubMed ID: 8380739
[TBL] [Abstract][Full Text] [Related]
13. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
14. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381
[TBL] [Abstract][Full Text] [Related]
15. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
[TBL] [Abstract][Full Text] [Related]
16. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
[TBL] [Abstract][Full Text] [Related]
17. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
Maehara N; Matsumoto K; Kuba K; Mizumoto K; Tanaka M; Nakamura T
Br J Cancer; 2001 Mar; 84(6):864-73. PubMed ID: 11259105
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
Shimabukuro K; Ichinose S; Koike R; Kubota T; Yamaguchi M; Miyasaka M; Aso T
Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
20. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
